Pneumonia in a nursing home

P J Drinka1, C Gauerke, S Voeks

  • 1Wisconsin Veterans Home, King 54946-0620.

Insights

This study investigated atypical pneumonia causes in nursing home residents. Serological tests did not confirm atypical organisms, highlighting the need for broad-spectrum antibiotics covering common bacteria.

Area of Science:

  • Infectious Diseases
  • Geriatric Medicine
  • Microbiology

Background:

  • Radiologic pneumonia is common in nursing home residents.
  • Atypical organisms are potential, yet often unconfirmed, causes of pneumonia in this population.

Purpose of the Study:

  • To determine if atypical organisms (Legionella, Mycoplasma, Chlamydia) cause radiologic pneumonia in nursing home residents.
  • To evaluate the efficacy of serological testing for diagnosing atypical pneumonia in this demographic.

Main Methods:

  • Serological examinations for Legionella, Mycoplasma, and Chlamydia were performed on nursing home residents with pneumonia.
  • Sputum cultures were analyzed, and mortality rates were reviewed over a one-year period.
  • Fifty-six pneumonia episodes in residents with a mean age of 78 years were studied.

Main Results:

  • No significant fourfold titer changes were observed, failing to serologically confirm atypical pneumonia.
  • Sputum cultures identified common bacteria such as Streptococcus pneumoniae, Hemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus.
  • The two-month mortality rate among the studied residents was 21%.

Conclusions:

  • Serological testing did not confirm atypical organisms as a cause of radiologic pneumonia in this nursing home cohort.
  • Antibiotic selection for pneumonia in nursing home residents should prioritize coverage for prevalent pathogens like Hemophilus influenzae, Moraxella, and Staphylococcus.
  • Clinical presentation remains a crucial factor in guiding antibiotic therapy decisions.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...